Inhibitors of Sterol Synthesis. Morphological Studies in Rats after Dietary Administration of 5α-Cholest-8(14)-en-3β-ol-15-one,a Potent Hypocholesterolemic Compound
Free accessResearch articleFirst published online April, 1989
Inhibitors of Sterol Synthesis. Morphological Studies in Rats after Dietary Administration of 5α-Cholest-8(14)-en-3β-ol-15-one,a Potent Hypocholesterolemic Compound
The morphological effects of short-term (9 days) dietary administration (0.1% in a laboratory chow diet) of 5α-cholest-8(14)-cn-3β-ol-15-onc, a novel regulator of cholesterol metabolism with significant hypocholesterolemic activity, has been studied in young male rats. Control animals included rats fed the basal diet ad libitum and a series of rats pair-fed to the individual experimental animals. At the time of necropsy, the morphological changes in rats which have been observed in rats following treatment with other absorbable hypolipidemic agents (myeloid bodies with triparanol, increased peroxisomes with clofibrate, and proliferation of smooth endoplasmic reticulum with compactin and mevinolin) were not apparent on ultrastructural examination of livers of rats treated with the 15-ketosterol. Two changes were observed in the rats fed the 15-ketosterol: a decrease in adipose tissue and enlargement of the small intestine. Diminished fat was also noted in the pair-fed controls and was presumably due to decreased food consumption. The intestines of rats fed the 15-ketosterol were morphometrically most enlarged in the jejunal region. Morphologically, this increase was distinguished by increased depth of crypts of Lieberkuhn and pseudostratification of epithelium at the base of the villi. These changes were qualitatively and quantitatively similar to the adaptive changes reported in the rat after resection of small bowel or following intestinal bypass (segment of bowel remaining in continuity). The morphological changes induced in the rat by administration of the 15-ketosterol were not observed in 4 baboons which received the compound orally at doses of 50, 75, or 100 mg per kilogram of body weight for up to 3 months.
1. Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg G, Hensens O, Hirshfield J, Hoogsteen K, Liesch J, and Springer J (1980). Mevinolin: A highly potent competitive inhibitor of hydroxymethyl-glutaryl-coenzyme A reductase and a cholesterol lowering agent.Proc. Natl. Acad. Sci. USA77: 3957–3961.
2.
2. Avigan J, Steinberg D, Thompson MJ, and Mossitig E (1960). The mechanism of action of MER-29.Progr. Cardiovasc. Dis.2: 525–530.
3.
3. Avigan J, Steinberg D, Vroman HE, and Mossetig E (1960). Studies of cholesterol biosynthesis. I. The identification of desmosterol in serum and tissues of animals and man treated with MER-29. J. Biol. Chem.235:3123–3126.
4.
4. Bochkov NP (1959). Morphological changes in the jejunum and ileum of rats after wide resection of the small intestine.Bull. Exp. Biol. Med.47: 339–343.
5.
5. Clayton RB, Nelson AN, and Frantz ID Jr (1963). The skin sterols of normal and triparanol-treated rats.J. Lipid Res.4: 166–176.
6.
6. Cohen AJ and Grasso P (1981). Review of the hepatic response to hypolipidemic drugs in rodents and assessment of its toxicological significance to man.Fd. Cosmet. Toxicol.19: 585–605.
7.
7. Endo A, Kuroda M, and Tanzawa K (1976). Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.FEBS Lett.72: 323–326.
8.
8. Frantz ID Jr, Mobberley ML, and Schroepfer GJ Jr (1960). Effects of MER-29 on the intermediary metabolism of cholesterol. Progr. Cardiovasc. Dis.2:511–518.
9.
9. Hess R, Staubli W, and Reiss W (1965). Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyratc in the rat.Nature (London)208: 856–858.
10.
10. Hruban Z, Swift H, and Slesers A (1965). Effect of triparanol and diethylamine on the fine structure of hepatocytes and pancreatic acinar cells.Lab. Invest.14: 1652–1672.
11.
11. Kisic A, Taylor AS, Chamberlain JS, Parish EJ, and Schroepfer GJ Jr (1978). Inhibitors of sterol synthesis. Further studies of the effect of 5α-cholest-8(14)-en-3β-ol-15-one on serum cholesterol levels of rats. Fed. Proc.37: 1663.
12.
12. Luna LG (1968). Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, 3rd ed.McGraw-Hill Book Company, New York.
13.
13. Miller LR, Needleman DH, Brabson JS, Wang K-S, and Schroepfer GJ (1987). 5α-cholest-8(14)-en-3β-ol-15-one. A competitive substrate for acyl coenzyme A: cholesterol acyl transferase.Biochem. Biophys. Res. Commun.148: 934–940.
14.
14. Miller LR, Pinkerton FD, and Schroepfer GJ Jr (1980). 5α-cholcst-8(14)-en-3β-ol-15-one, a potent inhibitor of sterol synthesis, reduces the levels of activity of enzymes involved in the synthesis and reduction of 3-hydroxy-3-methylglutaryl coenzyme A in CHO-Kl cells.Biochem. Internal.1: 223–228.
15.
15. Nygaard K (1967). Resection of the small intestine in rats. III. Morphological changes in the intestinal tract.Acta Chir. Scand.133: 233–248.
16.
16. Needleman DH, Strong K, Stemke KA, Brabson JS, Kisic A, and Schroepfer GJ Jr (1987). Inhibitors of sterol synthesis. Effect of dietary 5α-cholest-8(14)-en-3β-ol-15-one on ACAT activity of jejunal microsomes of the rat.Biochem. Biophys. Res. Commun.148: 920–925.
17.
17. Parish EJ, Spike TE, and Schroepfer GJ Jr (1977). Sterol synthesis. Chemical synthesis of 3β-benzoyloxy-14α, 15α-epoxy-5α-cholest-7-ene, a key intermediate in the synthesis of 15-oxygenatcd sterols.Chem. Phys. Lipids18: 233–239.
18.
18. Pinkerton FD, Izumi A, Anderson CM, Miller LR, Kisic A, and Schroepfer GJ Jr (1982). 14α-ethyl-5α-cholest-7-ene-3β, 15α-diol, a potent inhibitor of sterol biosynthesis, has two sites of action in cultured cells.J. Biol. Chem.257: 1929–1936.
19.
19. Scallen TJ, Condie RM, and Schroepfer GJ Jr (1962). Inhibition by triparanol of cholesterol formation in the brain of the newborn mouse.J. Neurochem.9: 99–103.
20.
20. Schroepfer GJ Jr (1961). Conversion of zymosterol-C14 and zymostenol-H3 to cholesterol by rat liver homogenatcs and intact rats.J. Biol. Chem.236: 1668–1673.
21.
21. Schroepfer GJ Jr, Christophe A, Needleman DH, Kisic A, and Sherrill BC (1987). Dietary administration of 5α-cholcst-8(14)-en-3β-ol-l 5-one inhibits the intestinal absorption of cholesterol. Biochem.Biophys. Res. Commun.146: 1003–1008.
22.
22. Schroepfer GJ Jr, Monger D, Taylor AS, Chamberlain JS, Parish EJ, Kisic A, and Kandutsch AA (1977). Inhibitors of sterol synthesis. Hypocholesterolemic action of dietary 5α-cholest-8(14)-en-3β-ol-15-one in rats and mice.Biochem. Biophys. Res. Commun.78: 1227–1233.
23.
23. Schroepfer GJ Jr, Parish EJ, Chen HW, and Kandutsch AA (1976). Inhibition of cholesterol biosynthesis in L cells and in primary cultures of liver cells by 15-oxygenatcd sterols. Fed. Proc.35: 1697.
24.
24. Schroepfer GJ Jr, Parish EJ, Chen HW, and Kandutsch AA (1977). Inhibition of sterol biosynthesis in L cells and mouse liver cells by 15-oxygenated sterols.J. Biol. Chem.252: 8975–8980.
25.
25. Schroepfer GJ Jr, Parish EJ, Kisic A, Jackson EM, Farley CM, and Mott GE (1982). 5α-cholest-8(14)-en-3β-ol-15-one, a potent inhibitor of sterol biosynthesis, lowers serum cholesterol and alters the distribution of cholesterol in lipoproteins of baboons.Proc. Natl. Acad. Sci. USA79: 3042–3046.
26.
26. Schroepfer GJ Jr, Sherrill BC, Wang K-S, Wilson WK, Kisic A, and Clarkson TB (1984). 5α-cholest-8(14)-en-3β-ol-15-one lowers serum cholesterol and induces profound changes in the levels of lipoprotein cholesterol and apoproteins in monkeys fed a diet of moderate cholesterol content.Proc. Natl. Acad. Sci. USA81: 6861–6865.
27.
27. Sclafani A, Koopmans HS, Vasselli JR, and Reichman M (1978). Effects of intestinal bypass surgery on appetite, food intake, and body weight in obese and lean rats. Am. J. Physiol.234: E389–E398.
28.
28. Singer II, Kawka DW, Kazazis DM, Alberts AW, Chen JS, Huff JW, and Ness GC (1984). Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat livers.Proc. Nat. Acad. Sci. USA81: 5556–5560.
29.
29. Steinberg D and Avigan J (1960). Studies of cholesterol biosynthesis. II. The role of desmosterol in the biosynthesis of cholesterol. J. Biol. Chem.235:3127–3129.
30.
30. Tanzawa K and Endo A (1979). Kinetic analysis of the reaction catalyzed by rat-liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase using two specific inhibitors.Eur. J. Biochem.98: 195–201.
31.
31. Tilson DM and Knight HK (1970). Adaptation of functioning and bypassed segments of ileum during compensatory hypertrophy of the gut.Surgery67: 687–693.
32.
32. Williamson RCN, Buchholtz TW, and Malt RA (1978). Humoral stimulation of cell proliferation in small bowel after transection and resection in rats.Gastroenterology75: 249–254.
